Annamalai replaces Santosh Babu as Ckm SP; Balakrishna is new Udupi SP

Bengaluru, Apr 28: There are a total of 523 COVID-19 positive cases have been confirmed in the state, Department of Health and Family Welfare of Karnataka informed on Tuesday.
It informed that there are 295 active COVID-19 cases in Karnataka presently, while 207 patients have been discharged, 20 deaths have been reported.

According to a district-wise breakup, a maximum of 131 cases were reported from Bengaluru urban, followed by Mysuru with 87 cases and Belagavi with 52 cases.

India's total number of coronavirus positive cases rises to 29,974 (including 22010 active cases, 7027 cured/discharged/migrated and 937 deaths), Ministry of Health and Family Welfare said on Tuesday.

Bengaluru, Jul 20: The Karnataka Congress on Monday slammed the State government's decision to distribute beds used by COVID-19 patients to Government-run hostels and called it as a "ridiculous" decision.

"It's ridiculous that the Govt plans to distribute beds used by COVID patients to Govt run hostels," read a tweet from the Karnataka Congress president DK Shivkumar.

He further said that the Karnataka Chief Minister BS Yediyurappa should give these beds to his ministers, MLAs and officials.

He further went on to urge parents and students to speak "against this move" by the State government.

"Let CM @BSYBJP give these beds to his Ministers, MLAs & Officials! We are launching a movement against this Govt & appeal to parents, students & youths to speak against this move," Shivkumar's tweet read further.

Along with the tweet he also shared a video as well.

Karnataka reported 3,648 COVID-19 cases and 72 deaths on Monday, taking active cases to 42,216 and death toll to 1,403. Bengaluru recorded the highest number of cases and deaths today at 1,452 & 31, respectively, said the State Health Department.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.